Recycling N-acetylcysteine: A review of evidence for adjunctive therapy in schizophrenia

INTRODUCTION: All symptoms in schizophrenia may impact functioning. Although Food and Drug Administration-approved medications typically benefit positive symptoms, negative symptoms are generally refractory to medication interventions. N-acetylcysteine's (NAC) influence on glutamatergic neurotr...

Descripción completa

Detalles Bibliográficos
Autores principales: Willborn, Robert J., Hall, Colleen P., Fuller, Matthew A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2019
Materias:
Literature Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513056/
https://www.ncbi.nlm.nih.gov/pubmed/31123658
http://dx.doi.org/10.9740/mhc.2019.05.116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513056/
https://www.ncbi.nlm.nih.gov/pubmed/31123658
http://dx.doi.org/10.9740/mhc.2019.05.116

Ejemplares similares